PharmaEssentia Company

PharmaEssentia develops treatments for myeloproliferative neoplasms, hepatitis and other diseases.
Industry: Genomic and Epigenominc Instabillity
Visit Website
info@pharmaessentia.com
Register and Claim Ownership